Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs

Схожие документы

• Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: analysis of structural data for future drug design
  по: Ciccone, Lidia, et al.
  Опубликовано: (2020)
• The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1
  по: Lidia Ciccone, et al.
  Опубликовано: (2020-05-01)
• The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1
  по: Ciccone, Lidia, et al.
  Опубликовано: (2020)
• Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer’s Disease
  по: Ciccone, Lidia, et al.
  Опубликовано: (2021)
• Copper mediated amyloid-β binding to Transthyretin
  по: Ciccone, Lidia, et al.
  Опубликовано: (2018)